Strata Critical Medical Profit Margin

The latest profit margin for SRTA is 18.98% as of June 2026. That compares with -7.46% in the prior-year period — up 354.3% year over year. That is above the Industrials sector average of 7.9%. Investors often review this figure alongside Strata Critical Medical's historical trend and sector peers before judging valuation or financial health.

Over the past year, SRTA's profit margin moved from -7.46% to 18.98% — a 354.3% year-over-year increase. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Strata Critical Medical's valuation or profitability profile.

Against Industrials companies, SRTA currently prints 18.98% for profit margin, while the sector average sits near 7.9%. That is roughly 140.1% above the sector mean. Large gaps often invite a closer look at Strata Critical Medical's growth, margins, and balance sheet.

Profit Margin shows how effectively Strata Critical Medical converts resources into returns. At 18.98%, SRTA may look efficient or underperforming depending on peer benchmarks and trend direction. That compares with -7.46% in the prior-year period — up 354.3% year over year. Pair the percentage with revenue growth and leverage for a fuller health check.

After noting SRTA's profit margin (18.98%), review year-over-year change from -7.46%, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.